These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 31298421)

  • 1. No increased risk of nephrotoxicity associated with 5-aminosalicylic acid in IBD: a population-based cohort and nested case-control study.
    Jairath V; Hokkanen SRK; Guizzetti L; Boxall N; Campbell-Hill S; Patel H
    Aliment Pharmacol Ther; 2019 Aug; 50(4):416-424. PubMed ID: 31298421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer in Elderly Onset Inflammatory Bowel Disease: A Population-Based Study.
    Cheddani H; Dauchet L; Fumery M; Charpentier C; Marie Bouvier A; Dupas JL; Pariente B; Peyrin-Biroulet L; Savoye G; Gower-Rousseau C
    Am J Gastroenterol; 2016 Oct; 111(10):1428-1436. PubMed ID: 27481308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study.
    van Staa TP; Card T; Logan RF; Leufkens HG
    Gut; 2005 Nov; 54(11):1573-8. PubMed ID: 15994215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prevalence of Inflammatory Bowel Disease in Greenland.
    Gantzel RH; Vesterdal JD; Haase AM; Petersen AJ; Grønbæk H; Pedersen ML
    Inflamm Bowel Dis; 2023 Dec; 29(12):1879-1885. PubMed ID: 36702537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crohn's disease and ulcerative colitis. Occurrence, course and prognosis during the first year of disease in a European population-based inception cohort.
    Burisch J
    Dan Med J; 2014 Jan; 61(1):B4778. PubMed ID: 24393595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A four-decade analysis of the incidence trends, sociodemographic and clinical characteristics of inflammatory bowel disease patients at single tertiary centre, Kuala Lumpur, Malaysia.
    Mokhtar NM; Nawawi KNM; Verasingam J; Zhiqin W; Sagap I; Azman ZAM; Mazlan L; Hamid HA; Yaacob NY; Rose IM; Den ELN; Wan MS; Raja Ali RA
    BMC Public Health; 2019 Jun; 19(Suppl 4):550. PubMed ID: 31196184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
    Mak JWY; So J; Tang W; Yip TCF; Leung WK; Li M; Lo FH; Ng KM; Sze SF; Leung CM; Tsang SWC; Shan EHS; Chan KH; Lam BCY; Hui AJ; Chow WH; Chan FKL; Ng SC
    Scand J Gastroenterol; 2020 Mar; 55(3):279-286. PubMed ID: 32119788
    [No Abstract]   [Full Text] [Related]  

  • 8. Incidence and Prevalence of Crohn's Disease and Ulcerative Colitis in Olmsted County, Minnesota From 1970 Through 2010.
    Shivashankar R; Tremaine WJ; Harmsen WS; Loftus EV
    Clin Gastroenterol Hepatol; 2017 Jun; 15(6):857-863. PubMed ID: 27856364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review with meta-analysis: prevalence, risk factors and costs of aminosalicylate use in Crohn's disease.
    Ma C; Dutton SJ; Cipriano LE; Singh S; Parker CE; Nguyen TM; Guizzetti L; Gregor JC; Chande N; Hindryckx P; Feagan BG; Jairath V
    Aliment Pharmacol Ther; 2018 Jul; 48(2):114-126. PubMed ID: 29851091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of markers of early atherosclerosis in patients with inflammatory bowel disease.
    Cappello M; Licata A; Calvaruso V; Bravatà I; Aiello A; Torres D; Della Corte V; Tuttolomondo A; Perticone M; Licata G; Craxì A; Cammà C
    Eur J Intern Med; 2017 Jan; 37():83-89. PubMed ID: 27773555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong.
    Ng SC; Leung WK; Shi HY; Li MK; Leung CM; Ng CK; Lo FH; Hui YT; Tsang SW; Chan YK; Loo CK; Chan KH; Hui AJ; Chow WH; Harbord M; Ching JY; Lee M; Chan V; Tang W; Hung IF; Ho J; Lao WC; Wong MT; Sze SF; Shan EH; Lam BC; Tong RW; Mak LY; Wong SH; Wu JC; Chan FK; Sung JJ
    Inflamm Bowel Dis; 2016 Aug; 22(8):1954-60. PubMed ID: 27416041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuing or stopping 5-aminosalicylates in patients with inflammatory bowel disease on anti-TNF therapy: A nationwide population-based study.
    Seo J; Kim S; Hong SW; Hwang SW; Park SH; Yang DH; Byeon JS; Myung SJ; Yang SK; Kim YJ; Ye BD
    Aliment Pharmacol Ther; 2024 Aug; 60(3):389-400. PubMed ID: 38866064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statins Associated With Decreased Risk of New Onset Inflammatory Bowel Disease.
    Ungaro R; Chang HL; Côté-Daigneault J; Mehandru S; Atreja A; Colombel JF
    Am J Gastroenterol; 2016 Oct; 111(10):1416-1423. PubMed ID: 27296939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. International variation in medication prescription rates among elderly patients with inflammatory bowel disease.
    Benchimol EI; Cook SF; Erichsen R; Long MD; Bernstein CN; Wong J; Carroll CF; Frøslev T; Sampson T; Kappelman MD
    J Crohns Colitis; 2013 Dec; 7(11):878-89. PubMed ID: 23018106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease course of inflammatory bowel disease unclassified in a European population-based inception cohort: An Epi-IBD study.
    Burisch J; Zammit SC; Ellul P; Turcan S; Duricova D; Bortlik M; Andersen KW; Andersen V; Kaimakliotis IP; Fumery M; Gower-Rousseau C; Girardin G; Valpiani D; Goldis A; Brinar M; Čuković-Čavka S; Oksanen P; Collin P; Barros L; Magro F; Misra R; Arebi N; Eriksson C; Halfvarson J; Kievit HAL; Pedersen N; Kjeldsen J; Myers S; Sebastian S; Katsanos KH; Christodoulou DK; Midjord J; Nielsen KR; Kiudelis G; Kupcinskas L; Nikulina I; Belousova E; Schwartz D; Odes S; Salupere R; Carmona A; Pineda JR; Vegh Z; Lakatos PL; Langholz E; Munkholm P;
    J Gastroenterol Hepatol; 2019 Jun; 34(6):996-1003. PubMed ID: 30562421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort.
    Burisch J; Pedersen N; Čuković-Čavka S; Brinar M; Kaimakliotis I; Duricova D; Shonová O; Vind I; Avnstrøm S; Thorsgaard N; Andersen V; Krabbe S; Dahlerup JF; Salupere R; Nielsen KR; Olsen J; Manninen P; Collin P; Tsianos EV; Katsanos KH; Ladefoged K; Lakatos L; Björnsson E; Ragnarsson G; Bailey Y; Odes S; Schwartz D; Martinato M; Lupinacci G; Milla M; De Padova A; D'Incà R; Beltrami M; Kupcinskas L; Kiudelis G; Turcan S; Tighineanu O; Mihu I; Magro F; Barros LF; Goldis A; Lazar D; Belousova E; Nikulina I; Hernandez V; Martinez-Ares D; Almer S; Zhulina Y; Halfvarson J; Arebi N; Sebastian S; Lakatos PL; Langholz E; Munkholm P;
    Gut; 2014 Apr; 63(4):588-97. PubMed ID: 23604131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy.
    Campbell S; Ghosh S
    Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1297-301. PubMed ID: 11692054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Healthcare Utilisation and Drug Treatment in a Large Cohort of Patients with Inflammatory Bowel Disease.
    Cars T; Wettermark B; Löfberg R; Eriksson I; Sundström J; Lördal M
    J Crohns Colitis; 2016 May; 10(5):556-65. PubMed ID: 26733406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.